While the United States is still the largest market by revenue, Europe, Middle East, and Africa (EMEA) and Asia Pacific (APAC) each represent 21% of revenue in 2022, per Figure 2. Such geographic diversity positions the company to grow strongly as consumers in emerging markets attain greater spending power. These actions have bolstered positions in Self Care, Skin Health and Essential Health. We are committed to continuously improving our sustainability efforts through our brands, packaging and operations, delivering on the expectations of today’s consumers. This site is governed solely by applicable U.S. laws and governmental regulations.
Kenvue plans to pay a dividend
These non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation. These non-GAAP financial measures should be considered supplements to, not substitutes for, or superior to, the corresponding financial measures calculated in accordance with U.S. For full year 2024, Kenvue continues to expect reported Interest expense, net to be approximately $400 million.
Kenvuers in action: Giving back and creating change
But while that diversification will add safety, it won't necessarily make for a good growth investment. Kenvue projects that its top line will grow at a compounded annual growth rate of https://www.1investing.in/ between 3% and 4% through 2025. That again highlights why the business might make more sense for risk-averse dividend investors than for those seeking attractive growth opportunities.
Our Services
Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer. Kenvue (KVUE Quick QuoteKVUE - Free Report) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price. Mr. Perry currently serves as President and Chief Executive Officer of Circana, a global provider of technology, data, and predictive analytics for the consumer, retail and media sectors.
Winning in-store presence and prominence, category leading consumer and healthcare professional engagement, and science backed innovation drove broad-based strength across the portfolio. A number of other large investors also recently bought and sold shares of KVUE. Beaumont Financial Advisors LLC lifted its position in shares of Kenvue by 3.0% during the fourth quarter. Beaumont Financial Advisors LLC now owns 17,532 shares of the company's stock worth $377,000 after purchasing an additional 509 shares in the last quarter.
- A number of other large investors also recently bought and sold shares of KVUE.
- The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool Foundation.
- ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
- In addition, other companies may use similarly titled non-GAAP financial measures that are calculated differently from the way the Company calculates such measures.
In fact, Kenvue’s return on invested capital (ROIC) ranks nearly last among its competition. Only The Clorox Company CLX has a lower ROIC of the companies in Figure 3. We’ve always prioritized science as the core of how we provide care, and this will never change. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice.
The Board has appointed Kathleen M. Pawlus and Kirk L. Perry as new independent directors, effective August 15, 2024, and December 1, 2024, respectively. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services. David is a distinguished investment strategist and corporate finance expert. He is author of the Chapter “Modern Tools for Valuation” in The Valuation Handbook (Wiley Finance 2010).
Pinnacle Bancorp Inc. boosted its holdings in shares of Kenvue by 51.3% in the fourth quarter. Pinnacle Bancorp Inc. now owns 1,552 shares of the company's stock valued at $33,000 after acquiring an additional 526 shares during the period. Manchester Capital Management LLC lifted its holdings in shares market to book ratio of Kenvue by 80.8% during the first quarter. Manchester Capital Management LLC now owns 1,186 shares of the company's stock worth $25,000 after purchasing an additional 530 shares during the period. Tradition Wealth Management LLC lifted its holdings in Kenvue by 2.8% in the fourth quarter.
One thing investors will like about the stock is that Kenvue stated in its prospectus that it expects to pay a quarterly cash dividend of $0.20 per share later this year. Assuming that is the case and the company pays every quarter, that would result in a yield of around 3.1% based on a share price of $26, which would be higher than the S&P 500 average of 1.7%. “We believe that daily self-care rituals add up over time and have a profound cumulative impact on your wellbeing.
Our experts picked 7 Zacks Rank #1 Strong Buy stocks with the best chance to skyrocket within the next days. Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell). Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. Our proprietary measures of Core Earnings and Earnings Distortion materially improve stock picking and forecasting of profits. Johnson & Johnson, after spinning off Kenvue, will continue to own 92% of the voting power in the newly formed company.
He is a seasoned consumer products and brand strategist, with more than 30 years of consumer packaged goods and technology experience at two of the world’s largest and most respected companies, Procter & Gamble and Google. Upon joining the Board, Mr. Perry will serve as a member of the Compensation & Human Capital Committee. At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress.
